ProText Mobility (ProText Mobility) Debt-to-Equity : -0.22 (As of Sep. 2014)

View and export this data going back to 2003. Start your Free Trial

What is ProText Mobility Debt-to-Equity?

ProText Mobility's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2014 was $1.42 Mil. ProText Mobility's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2014 was $0.00 Mil. ProText Mobility's Total Stockholders Equity for the quarter that ended in Sep. 2014 was $-6.56 Mil. ProText Mobility's debt to equity for the quarter that ended in Sep. 2014 was -0.22.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for ProText Mobility's Debt-to-Equity or its related term are showing as below:

TXTM's Debt-to-Equity is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.145
* Ranked among companies with meaningful Debt-to-Equity only.

ProText Mobility Debt-to-Equity Historical Data

The historical data trend for ProText Mobility's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ProText Mobility Debt-to-Equity Chart

ProText Mobility Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Debt-to-Equity

Get a 7-Day Free Trial

-0.76

-0.68

-0.37

-0.33

-0.25

ProText Mobility Quarterly Data
	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14
Debt-to-Equity	Get a 7-Day Free Trial															-0.26	-0.25	-0.23	-0.22	-0.22

Competitive Comparison of ProText Mobility's Debt-to-Equity

For the Biotechnology subindustry, ProText Mobility's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ProText Mobility's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ProText Mobility's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where ProText Mobility's Debt-to-Equity falls into.

ProText Mobility Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

ProText Mobility's Debt to Equity Ratio for the fiscal year that ended in Dec. 2013 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.429	+	0.004)	/	-5.699
	=	-0.25

ProText Mobility's Debt to Equity Ratio for the quarter that ended in Sep. 2014 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.42	+	0)	/	-6.558
	=	-0.22

ProText Mobility (OTCPK:TXTM) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

ProText Mobility Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of ProText Mobility's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

ProText Mobility (ProText Mobility) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProText Mobility Inc (OTCPK:TXTM) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

One West Las Olas Boulevard, Suite 500, Fort Lauderdale, FL, USA, 33301

Website

https://www.protxtm.com

ProText Mobility Inc is a Biotech Company developing a Hemp/CBD - Cannabis medicines platform for the legal cannabis industry, using proprietary live plant extraction processes & technologies. Protext has engaged in the research, testing, and development of bioavailable botanical products all-natural ingredients formulated for nutraceuticals and pharmaceutical applications through proprietary live plant extraction technology.

Executives

Peter Sealey

director

37400 CENTRAL COURT, NEWARK CA 94560